Drug Profile
Ritipenem acoxil
Alternative Names: FC/TA 891; FCE 22891; PenemacLatest Information Update: 29 Aug 2006
Price :
$50
*
At a glance
- Originator Pfizer
- Developer Pfizer; Tanabe Seiyaku
- Class Antibacterials; Penems; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections